YL

Yuan Liu

AP Araxes Pharma: 7 patents #5 of 8Top 65%
LY Lycera: 1 patents #12 of 21Top 60%
ME Mediatek: 1 patents #173 of 483Top 40%
Merck: 1 patents #377 of 961Top 40%
📍 Hsinchu, CA: #15 of 193 inventorsTop 8%
Overall (2019): #7,832 of 560,194Top 2%
10
Patents 2019

Issued Patents 2019

Showing 1–10 of 10 patents

Patent #TitleCo-InventorsDate
10515939 Wafer-level package having multiple dies arranged in side-by-side fashion and associated yield improvement method Yi-Hung Chen 2019-12-24
10428064 Fused-tricyclic inhibitors of KRAS and methods of use thereof Liansheng Li, Jun Feng, Yun Oliver Long, Tao Wu, Pingda Ren +1 more 2019-10-01
10414757 2-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereof Liansheng Li, Jun Feng, Yun Oliver Long, Tao Wu, Pingda Ren +1 more 2019-09-17
10377743 Inhibitors of RAS and methods of use thereof Liansheng Li, Jun Feng, Pingda Ren, Yi Liu, Tao Wu +1 more 2019-08-13
10370386 Substituted quinolines as inhibitors of KRAS G12C Liansheng Li, Jun Feng, Tao Wu, Pingda Ren, Yi Liu +1 more 2019-08-06
10351550 Substituted quinazoline compounds and methods of use thereof Liansheng Li, Jun Feng, Yun Oliver Long, Tao Wu, Pingda Ren +1 more 2019-07-16
10280172 Inhibitors of KRAS G12C mutant proteins Liansheng Li, Jun Feng, Yun Oliver Long, Pingda Ren, Yi Liu 2019-05-07
10261928 Wafer-level package having one die with its clock source shared by multiple dies and associated clock generating method Yi-Hung Chen 2019-04-16
10246424 Substituted quinazoline compounds and methods of use thereof Liansheng Li, Jun Feng, Yun Oliver Long, Tao Wu, Pingda Ren +1 more 2019-04-02
10221146 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2019-03-05